发明名称 HCV RNA REPLICATION INHIBITOR
摘要 <P>PROBLEM TO BE SOLVED: To provide the use of a compound useful as a human hepatitis C virus RNA replication inhibitor or a therapeutic agent for human hepatitis C virus infectious diseases and a method of screening the compound. <P>SOLUTION: N-acetylglucosamine acts to inhibit the RNA replication of human hepatitis C virus and accordingly, is useful as a human hepatitis C virus RNA replication inhibitor, a therapeutic agent for human hepatitis C virus infectious disease or the like, and the use of an N-acetylglucosamine derivative using N-acetylglucosamine as a lead compound enables screening of the human hepatitis C virus RNA replication inhibitor and the human hepatitis C virus infectious disease therapeutic agent. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012171870(A) 申请公布日期 2012.09.10
申请号 JP20110032399 申请日期 2011.02.17
申请人 KEIO GIJUKU;HAMAMATSU UNIV SCHOOL OF MEDICINE;YAIZU SUISANKAGAKU INDUSTRY CO LTD 发明人 SATO TOMONORI;SUZUKI TETSURO;KAWAGUCHI MITSUAKI
分类号 A61K31/7008;A61P1/16;A61P31/14;C07H5/06;C12Q1/02;C12Q1/68;G01N33/15;G01N33/50 主分类号 A61K31/7008
代理机构 代理人
主权项
地址